what dietary phosphorus, protein, and omega-3 targets should I aim for when managing CKD in cats?

Question

Accepted Answer

For azotemic CKD (IRIS stages 2–4), dietary phosphorus restriction is the highest-priority nutritional intervention, with protein restriction added at stage 2 (consideration) through stage 3 (recommendation), and long-chain omega-3 polyunsaturated fatty acid supplementation introduced at stage 2.46 Phosphorus targets are defined by serum concentration rather than a single universal dietary intake figure. IRIS serum phosphorus targets exist for stages 1–4, though there is no consensus on the specific dietary phosphorus intake required to achieve them across all CKD stages.1 What is established is that dietary phosphorus restriction at or below the minimum accepted dietary requirement slows disease progression and reduces complications in cats with CKD.5 In healthy adult cats, adverse renal effects — including decreased glomerular filtration rate, increased serum creatinine, renal echogenicity changes, and nephrolithiasis — have been documented when dietary phosphorus exceeds 3.6 g/1000 kcal metabolizable energy (ME) combined with a calcium-to-phosphorus (Ca:P) ratio below 1.0.8 A diet containing 3.0 g P/1000 kcal ME with a Ca:P ratio of 0.4 produced transient renal changes including decreased creatinine clearance, glucosuria, and microalbuminuria in healthy adult cats.8 These thresholds inform the upper boundary of safe phosphorus intake even before CKD is diagnosed. Critically, aggressive phosphorus restriction carries its own risk in early CKD. Cats with IRIS stage 1–2 CKD fed a low-phosphorus diet (0.84 g/Mcal, Ca:P = 1.9) for 17 months developed hypercalcemia and markedly elevated fibroblast growth factor 23 (FGF-23), while serum phosphorus itself did not rise significantly.3 When those same cats were transitioned to a moderate-phosphorus regimen (1.4–1.6 g/Mcal, Ca:P = 1.4–1.6), serum calcium, phosphorus, and creatinine all remained within reference ranges, and FGF-23 decreased significantly.3 This supports targeting moderate rather than maximal phosphorus restr